1. Y Chromosome Loss Is a Frequent Event in Barrett’s Adenocarcinoma and Associated with Poor Outcome
   Heike Loeser et al, 2020, Cancers CrossRef
2. Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
   Elena Alexandrova et al, 2022, Frontiers in Genetics CrossRef
3. Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas
   Jan Rehkaemper et al, 2020, BMC Cancer CrossRef
4. Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies
   Margherita d'Errico et al, 2020, Cancer Treatment Reviews CrossRef
5. FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract
   Jan Albin et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
6. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
   Patrick Sven Plum et al, 2019, BMC Cancer CrossRef
7. Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses
   Hongnuan Wang et al, 2022, Frontiers in Immunology CrossRef
8. An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy
   Vanessa Szablewski et al, 2018, Oncotarget CrossRef
9. PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
   Ahlem Essakly et al, 2020, Translational Oncology CrossRef
10. Copy-number-gain of telomerase reverse transcriptase (hTERT) is associated with an unfavorable prognosis in esophageal adenocarcinoma
    Su Ir Lyu et al, 2023, Scientific Reports CrossRef